Meet The Team

Björn Dahl

PhD ERT

Björn is a very experienced toxicologist with  more than 28 years of discovery and development  experience gained mainly in AstraZeneca.  Björn has worked across multiple therapy areas and has particular experience in the Cardiovascular, Renal and Metabolism therapy areas.  He has been directly involved in bringing over 35 new candidate drugs to clinical trials and 4 to marketing approval.  Björn was co-chair of the EFPIA Preclinical Development Expert Working Group until 2018 and was EFPIA topic lead on the ICH S11 Expert Working Group on nonclinical safety testing of paediatric medicines.  Björn brings his judgement, wisdom and problem-solving skills to the design and delivery of nonclinical strategies.